Randomized clinical field trial of a bacterial kidney disease vaccine in Atlantic salmon, Salmo salar L
-
Published source details
Burnley T.A., Stryhn H., Burnley H.J. & Hammell K.L. (2010) Randomized clinical field trial of a bacterial kidney disease vaccine in Atlantic salmon, Salmo salar L. Journal of Fish Diseases, 33, 545-557.
Published source details Burnley T.A., Stryhn H., Burnley H.J. & Hammell K.L. (2010) Randomized clinical field trial of a bacterial kidney disease vaccine in Atlantic salmon, Salmo salar L. Journal of Fish Diseases, 33, 545-557.
Actions
This study is summarised as evidence for the following.
Action | Category | |
---|---|---|
Use vaccinations Action Link |
-
Use vaccinations
In 2010, a randomised, replicated, controlled study in Canada (Burnley et al., 2010) found the vaccine, Lipogen Forte V1, increased salmon, Salmo salar, survival during an outbreak of bacterial kidney disease when compared with an industry standard. Four other vaccines were not successful, relative to the industry standard vaccine. Groups of salmon were given one of four commercially available vaccines: Lipogen Forte V1, Renogen, Bayovac 5.1 Vet and Alpha Ject 4000. Mortality was measured weekly or biweekly for eight months.
Output references
|